Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151318 · ClinicalTrials.gov registry record
Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 12
- Enrollment target
NCT02151318 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 12 participants.
The verdict
NCT02151318 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
In this study, the investigators will collect tissue from patients undergoing trabeculectomy for primary open-angle glaucoma treatment. This tissue would normally be discarded. These trabecular meshwork (TM) cells can be cultured and used experimentally to better understand the mechanisms of glaucoma. These TM biopsies will be cultured on the same day as the trabeculectomy using established techniques.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02151318
The ClinicalTrials.gov registry entry for NCT02151318 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02151318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02151318 about?
NCT02151318 is a clinical study titled "Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies". In this study, the investigators will collect tissue from patients undergoing trabeculectomy for primary open-angle glaucoma treatment. This tissue would normally be discarded. These trabecular meshwork (TM) cells can be cultured and used experimentally to better understand the mechanisms of glaucom...
What is the current status of trial NCT02151318?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2014-12. Estimated completion is 2016-11.
Who is sponsoring clinical trial NCT02151318?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.